Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 32

Trial Status

Recruiting1
Terminated1

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT04299893Phase 2/3Recruiting
Ozone Therapy in Chemotherapy-induced Peripheral Neuropathy: RCT (O3NPIQ)
Chemotherapy-induced Peripheral NeuropathyPain SyndromePain, Neuropathic
StudydirectorStart date: 2020-11-30
NCT03660657Phase 2/3Terminated
Ozone Therapy in Refractory Ischemic Heart Disease.
Ischemic Heart Disease
StudydirectorStart date: 2020-02-26

Research Network

Collaboration Network

7 collaborators·15 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Francisco Rodríguez-Esparragón, BSc, PhD

Dr. Negrín University Hospital, Las Palmas, Spain

Similar
2 trials

Shared therapeutic areas:

Chemotherapy-induced Peripheral NeuropathyMyocardial IschemiaNeuralgia+2 more

Worked with same sponsors:

Bernardino Clavo, MD, PhDColegio Oficial de Médicos de Las Palmas+8 more
Collaborated on 2 trials
Similarity Score58%

Gustavo M Callico, Prof, PhD

Institute for Applied Microelectronics, University of Las Palmas de G. C., Spain

Moderately Similar
1 trials

Shared therapeutic areas:

Chemotherapy-induced Peripheral NeuropathyNeuralgiaPain secondary to chemotherapy-induced peripheral neuropathy+1 more

Worked with same sponsors:

Bernardino Clavo, MD, PhDCouncil of Gran Canaria+5 more
Collaborated on 1 trial
Similarity Score44%

Delvys Rodríguez-Abreu, MD

Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas, Spain

Moderately Similar
1 trials

Shared therapeutic areas:

Chemotherapy-induced Peripheral NeuropathyNeuralgiaPain secondary to chemotherapy-induced peripheral neuropathy+1 more

Worked with same sponsors:

Bernardino Clavo, MD, PhDCouncil of Gran Canaria+5 more
Collaborated on 1 trial
Similarity Score44%

Renata Linertová, PhD

Servicio de Evaluación. Servicio Canario de Salud. Spain

Related
1 trials

Shared therapeutic areas:

Myocardial Ischemia

Worked with same sponsors:

Bernardino Clavo, MD, PhDColegio Oficial de Médicos de Las Palmas+4 more
Collaborated on 1 trial
Similarity Score14%

Norberto Santana-Rodríguez, MD, PhD

King Faisal Specialist Hospital & Research Center, Riyadh, Kingdom of Saudi Arabia

Related
1 trials

Shared therapeutic areas:

Myocardial Ischemia

Worked with same sponsors:

Bernardino Clavo, MD, PhDColegio Oficial de Médicos de Las Palmas+4 more
Collaborated on 1 trial
Similarity Score14%

Celestina Amador, MD, PhD

Dr. Negrín University Hospital, Las Palmas, Spain

Related
1 trials

Shared therapeutic areas:

Myocardial Ischemia

Worked with same sponsors:

Bernardino Clavo, MD, PhDColegio Oficial de Médicos de Las Palmas+4 more
Collaborated on 1 trial
Similarity Score14%

Simon Haroutounian, PhD

Washington University School of Medicine

Related
8 trials

Shared therapeutic areas:

NeuralgiaChemotherapy-induced Peripheral Neuropathy
Similarity Score12%

Kassiani Theodoraki, phD, DESA

Aretaieion University Hospital

Related
15 trials

Shared therapeutic areas:

NeuralgiaPain Syndrome
Similarity Score12%

Frank Greenway, MD

Pennington Biomedical Research Center

Related
9 trials

Shared therapeutic areas:

Neuralgia
Similarity Score6%

Paul Perez, Dr

University Hospital, Bordeaux

Related
7 trials

Shared therapeutic areas:

Neuralgia
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04299893Phase 2/3StudyDirector

Ozone Therapy in Chemotherapy-induced Peripheral Neuropathy: RCT (O3NPIQ)

Chemotherapy-induced Peripheral NeuropathyPain SyndromePain, Neuropathic
Recruiting
NCT03660657Phase 2/3StudyDirector

Ozone Therapy in Refractory Ischemic Heart Disease.

Ischemic Heart Disease
Terminated

All 2 trials loaded